NR1H4 and metabolic dysfunction-associated steatotic liver disease: In contrast, Our previously published data showed that doramectin, abamectin, and ivermectin as FXR partial agonists (Jin et al., 2013; Jin et al., 2015) have significant therapeutic effects on NAFLD in a relatively low dose.